- CHMP recommends RYBREVANT® 🔍
- HUTCHMED Highlights Clinical Data to be Presented at the 2024 ...🔍
- Selecting Optimal First|Line Therapies for Patients With Acute ...🔍
- ESMO Congress 2019🔍
- Lung Cancer Awareness Month🔍
- Junshi Biosciences Announces UK MHRA Approval for Marketing🔍
- FDA Grants Rare Pediatric Designation to Elraglusib for Ewing ...🔍
- European Society for Medical Oncology 🔍
ESMO Congress
ESMO 2019, Europe's largest medical oncology conference
Fira de Barcelona for the first time hosts ESMO 2019, the most important congress in Europe dedicated to the latest advances against cancer.
CHMP recommends RYBREVANT® (amivantamab) in combination ...
... (ESMO) Congress, with longer-term follow-up data presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World ...
HUTCHMED Highlights Clinical Data to be Presented at the 2024 ...
HUTCHMED Highlights Clinical Data to be Presented at the 2024 ASH Annual Meeting and the 2024 ESMO Asia Congress. Hong Kong, Shanghai & Florham Park, NJ ...
Selecting Optimal First-Line Therapies for Patients With Acute ...
EANM Annual Congress · ESMO Congress · ESMO Gynecological Cancers Congress · World Congress on GI Cancer · Great Debates & Updates in GI ...
ESMO Congress 2019 | Barcelona, Spain
Save the date for the ESMO Congress 2019 taking place in Barcelona, Spain; 27 September-1 October 2019.
Lung Cancer Awareness Month: Potential new standard in NSCLC ...
... ESMO Congress. Read more. 5. Concurrent administration of chemoradiation and immunotherapy did not improve survival for patients with ...
Junshi Biosciences Announces UK MHRA Approval for Marketing
The results were first presented in an oral session during the ESMO Congress 2021 and later published in Cancer Cell and Journal of Clinical ...
FDA Grants Rare Pediatric Designation to Elraglusib for Ewing ...
... ESMO Asia Congress. 1. “TROPION-Lung01 was designed to test the potential to improve upon standard-of-care chemotherapy in a broad ...
European Society for Medical Oncology (ESMO) Congress 2014
European Society for Medical Oncology (ESMO) Congress 2014 : Read clinically focused news coverage of key developments from ESMO 2014.
Explore the latest in oncology at ESMOASIA24 - OncoDaily
ESMO – European Society for Medical Oncology shared a post on LinkedIn: ... ESMO 2024 Congress. September 13-17, 2024. ASCO Annual Meeting. May 30 ...
ESMO AI & Digital Oncology Congress 2025
The ESMO AI & Digital Oncology Congress 2025 will take place on 12-14 November 2025 in Berlin, Germany. Serving as a central hub for the latest research.
BioNTech takes partner Biotheus and cancer bispecifics in-house for ...
At the recent European Society for Medical Oncology (ESMO) congress, BioNTech reported early results from a Phase II study of BNT327 ...
Cantargia Publishes Interim Report for Third Quarter 2024
Cantargia presented new results at the ESMO Congress regarding the benefits with nadunolimab combination therapy after relapse on PD1 inhibitor ...
Will Durvalumab Transform Standard Care in MIBC?
... ESMO Congress 2024.1. “Adding durvalumab before and after surgery significantly reduced the chance of recurrence and extended survival, a ...
Junshi Biosciences Announces UK MHRA Approval for Marketing of ...
The results were first presented in an oral session during the ESMO Congress 2021 and later published in Cancer Cell and Journal of Clinical ...
Sutro Biopharma Reports Third Quarter 2024 Financial
... (ESMO) Congress 2024, demonstrating a 56% response rate at the recommended Phase 2 dose of luvelta (4.3 mg/kg) for this study. An expansion ...
FDA Sets Date For Resubmitted Dupixent in Inflammatory Skin ...
... (ESMO) Asia 2024 Congress in December 2024. ... These datat were presented at the European Society for Medical Oncology (ESMO) 2023 Congress.
ESMO Media Releases - European Society for Medical Oncology
The Molecular Analysis for Precision Oncology Congress 2024 (MAP) is the appointment where globally recognised experts will present and discuss research in ...
Cantargia AB (FRA:7V3) Q3 2024 Earnings Call Highlights
Positive clinical data was presented at the ESMO Congress for nadunolimab combination therapy, showing promising results after relapse PD1 ...
Quitting smoking early after cancer diagnosis improves survival
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress.